Alexander D. Macrae
2017
In 2017, Alexander D. Macrae earned a total compensation of $1.8M as President and Chief Executive Officer at Sangamo Biosciences, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $381,888 |
|---|---|
| Option Awards | $795,564 |
| Salary | $612,000 |
| Other | $6,404 |
| Total | $1,795,856 |
Macrae received $795.6K in option awards, accounting for 44% of the total pay in 2017.
Macrae also received $381.9K in non-equity incentive plan, $612K in salary and $6.4K in other compensation.
Rankings
In 2017, Alexander D. Macrae's compensation ranked 6,036th out of 14,666 executives tracked by ExecPay. In other words, Macrae earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,036 out of 14,666 | 59th |
Division Manufacturing | 2,216 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 699 out of 2,075 | 66th |
Industry group Drugs | 539 out of 1,731 | 69th |
Industry Biological Products, Except Diagnostic Substances | 98 out of 313 | 69th |
Source: SEC filing on April 24, 2018.
Macrae's colleagues
We found four more compensation records of executives who worked with Alexander D. Macrae at Sangamo Biosciences in 2017.